Therefore, we cannot exclude the possibility that Fbxw7 is a weak tumor suppressor, which would be sufficient to drive tumorigenesis with Kras mutation in a small number of mice if we utilized a much larger cohort of mice for the in vivo electroporation experiment. The gene discussed is KRAS; the disease is neoplasm.